Registration of Study Sample Clauses

Registration of Study. To the extent required by Applicable Law, it shall be the responsibility of the Sponsor to register the Study at (i) xxx.xxxxxxxxxxxxxx.xxx; (ii) any other registry the requirements of which are consistent with the guidelines of the International Committee of Medical Journal Editors (“ICMJE”) on trial registrations, in each case to the extent required by the ICMJE guidelines (as in effect at the time the Study begins) in order for the Study results to be eligible for publication in an ICMJE journal; or (iii) any other registry as might be required by Applicable Law. 3.5 Registrace studie. V rozsahu vyžadovaném platnými zákony bude zadavatel odpovídat za registraci studie (i) na webu xxx.xxxxxxxxxxxxxx.xxx; (ii) v jiném registru, jehož požadavky jsou v souladu s pokyny Mezinárodní komise vydavatelů lékařských časopisů (dále jen „ICMJE“) pro registrace klinických hodnocení, a to vždy v rozsahu požadovaném pokyny komise ICMJE (platnými v okamžiku zahájení studie), aby výsledky studie splňovaly požadavky na publikování v časopise ICMJE; nebo (iii) v jakémkoliv jiném registru pokud to bude požadováno platnými zákony.
Sample 1Sample 2See All (7)
AutoNDA by SimpleDocs
Registration of Study. In accordance with Title VIII of the Food and Drug Administration Amendments of 2007, 42 U.S.C. 282(j) et seq., Clinical Trial Databases, Sponsor acknowledges that it is the responsible Party with respect to this Study. Accordingly, Sponsor agrees to fully register this Study with the public registry xxxxxxxxxxxxxx.xxx before enrollment of the first subject at Institution and to submit all required results information to xxxxxxxxxxxxxx.xxx in a timely manner. To the extent possible within the context of xxxxxxxxxxxxxx.xxx, Sponsor agrees to submit results information in a manner acceptable to the International Committee of Medical Journal Editors.
Sample 1Sample 2
Registration of Study. Company shall register and report the results of the Study in accordance with the International Committee of Medical Journal Editors (ICMJE) clinical trial requirements for publication and as required under Applicable Law.
Sample 1
Registration of Study. Sponsor shall register the Study at xxx.xxxxxxxxxxxxxx.xxx.
Sample 1
Registration of Study. Prior to enrollment of the first subject in the Study, NACHO shall register the Study with xxx.xxxxxxxxxxxxxx.xxx, and equivalent registries, including all information recommended by the Uniform Requirements for Manuscripts Submitted to Biomedical Journals of the International Committee of Medical Journal Editors (see xxx.xxxxx.xxx).
Sample 1
Registration of Study. University shall register this Study on xxx.xxxxxxxxxxxxxx.xxx prior to the enrollment of the first Study subject. 3.3.
Sample 1
Registration of Study. To the extent required by Applicable Law, it shall be the responsibility of the Sponsor to register the Study at (i) xxx.xxxxxxxxxxxxxx.xxx; (ii) any other výhradně odpovědný za výplatu odměn všem členům personálu, který se na provádění klinického hodnocení podílí. Platby uskutečněné podle této smlouvy v žádném případě nepřesáhnou částku, která je uvedena v příloze B, bez předchozího písemného souhlasu zadavatele. 3.4
Sample 1
AutoNDA by SimpleDocs

Related to Registration of Study

  • Registrations on Form S-3 The Holders of Registrable Securities may at any time, and from time to time, request in writing that the Company, pursuant to Rule 415 under the Securities Act (or any successor rule promulgated thereafter by the Commission), register the resale of any or all of their Registrable Securities on Form S-3 or any similar short form registration statement that may be available at such time (“Form S-3”); provided, however, that the Company shall not be obligated to effect such request through an Underwritten Offering. Within five (5) days of the Company’s receipt of a written request from a Holder or Holders of Registrable Securities for a Registration on Form S-3, the Company shall promptly give written notice of the proposed Registration on Form S-3 to all other Holders of Registrable Securities, and each Holder of Registrable Securities who thereafter wishes to include all or a portion of such Holder’s Registrable Securities in such Registration on Form S-3 shall so notify the Company, in writing, within ten (10) days after the receipt by the Holder of the notice from the Company. As soon as practicable thereafter, but not more than twelve (12) days after the Company’s initial receipt of such written request for a Registration on Form S-3, the Company shall register all or such portion of such Holder’s Registrable Securities as are specified in such written request, together with all or such portion of Registrable Securities of any other Holder or Holders joining in such request as are specified in the written notification given by such Holder or Holders; provided, however, that the Company shall not be obligated to effect any such Registration pursuant to Section 2.3 hereof if (i) a Form S-3 is not available for such offering; or (ii) the Holders of Registrable Securities, together with the Holders of any other equity securities of the Company entitled to inclusion in such Registration, propose to sell the Registrable Securities and such other equity securities (if any) at any aggregate price to the public of less than $10,000,000.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!